Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Verizon
VZ
|
+$92M |
| 2 |
VRN
Veren
VRN
|
+$46M |
| 3 |
Perrigo
PRGO
|
+$25.1M |
| 4 |
VER
VEREIT, Inc.
VER
|
+$7.68M |
| 5 |
Liberty Global Class C
LBTYK
|
+$6.67M |
Top Sells
| 1 |
Apple
AAPL
|
+$51.6M |
| 2 |
COLE
COLE REAL ESTATE INVESTMENTS, INC COM
COLE
|
+$43.4M |
| 3 |
Exxon Mobil
XOM
|
+$42.4M |
| 4 |
Microsoft
MSFT
|
+$29.9M |
| 5 |
GE Aerospace
GE
|
+$26.8M |
Sector Composition
| 1 | Healthcare | 13.36% |
| 2 | Technology | 13.11% |
| 3 | Energy | 11.79% |
| 4 | Industrials | 11.1% |
| 5 | Consumer Staples | 10.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2026
Usana Health Sciences
USNA
$557M
| $603K | ﹤0.01% |
16,000
+3,400
| +27% | +$128K |
|
|
SAAS
2027
DELISTED
inContact, Inc.
SAAS
| $603K | ﹤0.01% |
62,800
+11,100
| +21% | +$107K |
|
2028
First Bancorp
FBP
$3.49B
| $602K | ﹤0.01% |
110,600
+26,100
| +31% | +$142K |
|
2029
American Vanguard Corp
AVD
$160M
| $600K | ﹤0.01% |
27,700
+6,200
| +29% | +$134K |
|
|
RCPT
2030
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
| $600K | ﹤0.01% |
14,300
+10,400
| +267% | +$436K |
|
2031
Griffon
GFF
$3.61B
| $599K | ﹤0.01% |
50,200
+12,100
| +32% | +$144K |
|
2032
Universal Electronics
UEIC
$62.3M
| $599K | ﹤0.01% |
15,600
+4,200
| +37% | +$161K |
|
|
IDIX
2033
DELISTED
IDENIX PHARMACEUTICALS INC
IDIX
| $595K | ﹤0.01% |
98,600
| – | – |
|
2034
Lesaka Technologies
LSAK
$362M
| $594K | ﹤0.01% |
59,600
+9,800
| +20% | +$97.7K |
|
|
MITT
2035
AG Mortgage Investment Trust
MITT
$244M
| $594K | ﹤0.01% |
11,300
+2,500
| +28% | +$131K |
|
|
TVTY
2036
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $593K | ﹤0.01% |
34,600
+9,400
| +37% | +$161K |
|
|
LBY
2037
DELISTED
Libbey, Inc.
LBY
| $593K | ﹤0.01% |
22,800
+5,300
| +30% | +$138K |
|
2038
TTM Technologies
TTMI
$4.83B
| $591K | ﹤0.01% |
69,900
+13,600
| +24% | +$115K |
|
|
LUMO
2039
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $591K | ﹤0.01% |
2,311
+389
| +20% | +$99.5K |
|
|
AVNR
2040
DELISTED
AVANIR PHARMACEUTICALS, INC CL A
AVNR
| $591K | ﹤0.01% |
160,900
+34,400
| +27% | +$126K |
|
2041
Park-Ohio Holdings
PKOH
$309M
| $590K | ﹤0.01% |
10,500
+1,600
| +18% | +$89.9K |
|
2042
Denny's
DENN
$264M
| $589K | ﹤0.01% |
91,600
+21,000
| +30% | +$135K |
|
|
RPXC
2043
DELISTED
RPX Corporation
RPXC
| $588K | ﹤0.01% |
36,100
+6,500
| +22% | +$106K |
|
|
WG
2044
DELISTED
Willbros Group
WG
| $588K | ﹤0.01% |
46,600
+10,100
| +28% | +$127K |
|
|
RLD
2045
DELISTED
REALD INC COM STK
RLD
| $586K | ﹤0.01% |
52,500
+11,400
| +28% | +$127K |
|
2046
BioCryst Pharmaceuticals
BCRX
$1.66B
| $584K | ﹤0.01% |
55,200
+11,400
| +26% | +$121K |
|
|
GSIG
2047
DELISTED
GSI GROUP INC COM STK (CDA)
GSIG
| $584K | ﹤0.01% |
44,700
+9,500
| +27% | +$124K |
|
2048
Photronics
PLAB
$1.33B
| $582K | ﹤0.01% |
68,200
+15,900
| +30% | +$136K |
|
2049
Ituran Location and Control
ITRN
$696M
| $580K | ﹤0.01% |
23,313
+3,229
| +16% | +$80.3K |
|
2050
First Interstate BancSystem
FIBK
$3.43B
| $579K | ﹤0.01% |
20,500
+4,800
| +31% | +$136K |
|